News Headlines Article

Growing cancer-testing company NeoGenomics raises $34M in offering
Sacramento Business Journal

Growing cancer-focused testing company NeoGenomics Inc. raised about $34.6 million in public offering of additional shares. In July, NeoGenomics completed its $6 million purchase of Path Logic, which is based in West Sacramento. The transaction included Path Logic’s labs in West Sacramento and Fresno. Path Logic operates as a subsidiary of NeoGenomics. Path Logic retainsits name and brand, said Steven Jones, executive vice president of finance with NeoGenomics.